Anixa Biosciences Stock Forecast for 2023 - 2025 - 2030

Updated on 02/04/2023

Stock Rating
8
Price Target
$11.00
Consensus
Outperform
Upside
150.57%
Analysts
1
Stock Rating
8
Upside
150.57%
Analysts
1
Price Target
$11.00

Anixa Biosciences Stock Forecast and Price Target

The average target price set lately by experts for Anixa Biosciences to reach by the end of the year is $11.00, which would imply a potential upside of approximately 150.57 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $11.00 and a low estimate of $11.00. If you are interested in ANIX stock, you should also look at its competitors.

$11.00

150.57% Upside

Outperform
Outperform

Anixa Biosciences Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Anixa Biosciences's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $4.75, which would mean an increase of 100.00%. Over the next eight years, experts predict that Anixa Biosciences's Fair Value will grow at a rate of 100.00%.

2023 Fair Value Forecast
$4.75
2024 Fair Value Forecast
$5.28
2025 Fair Value Forecast
$5.87
2026 Fair Value Forecast
$6.53
2027 Fair Value Forecast
$7.26
2028 Fair Value Forecast
$8.07
2029 Fair Value Forecast
$8.98
2030 Fair Value Forecast
$9.98
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ABT Stock Forecast Abbott Laboratories Outperform 10
$111.79 $120.97 11.82%
BDX Stock Forecast Becton, Dickinson and Outperform 17
$245.84 $268.00 11.86%
MARA Stock Forecast Marathon Digital Holdings Outperform 11
$7.07 $63.75 175.81%
QTRH Stock Forecast Quarterhill Outperform 8
C$1.98 C$3.45 64.14%
VHC Stock Forecast VirnetX Holding Corp - 6
$1.73 $36.00 39.88%

Anixa Biosciences Revenue Forecast for 2023 - 2025 - 2030

In the last year, Anixa Biosciences's Revenue has grown by 104.00%, rising from $250.00k to $510.00k. According to 0 analysts, Anixa Biosciences's Revenue will fall by 50.98% in the next year, reaching $250.00k. Professionals believe that By 2030, Anixa Biosciences's Revenue will fall to $421.24k – a 17.40% decrease from its current value.

2022 Rev Forecast
$250.00k
2023 Rev Forecast
$380.85k
2024 Rev Forecast
$404.54k
2025 Rev Forecast
$490.55k
2026 Rev Forecast
$396.12k
2027 Rev Forecast
$396.71k
2028 Rev Forecast
$404.86k
2029 Rev Forecast
$434.11k
2030 Rev Forecast
$421.24k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
AWH Stock Forecast Aspira Women's Health Buy 7
$0.49 $0.00 512.24%
NTIP Stock Forecast Network-1 Technologies - -2
$2.23 $0.00 15.70%
DSS Stock Forecast Document Security Systems Buy 0
$0.42 $0.00 423.81%

Anixa Biosciences Dividend per Share Forecast for 2023 - 2025 - 2030

Anixa Biosciences Free Cash Flow Forecast for 2023 - 2025 - 2030

Anixa Biosciences's Free Cash Flow has grown In the last year, rising from $-4.92M to $-6.20M – a growth of 26.02%. For the following year, the 0 analysts predict that Anixa Biosciences's Free Cash Flow will drop by 20.65%, reaching $-4.92M. In 2030, the professionals' prediction is that ANIX's Free Cash Flow will decrease by 11.93%, reaching $-5.46M.

2021 FCF Forecast
$-4919700.00
2022 FCF Forecast
$-5434464.61
2023 FCF Forecast
$-5360193.59
2024 FCF Forecast
$-5680733.17
2025 FCF Forecast
$-5420934.31
2026 FCF Forecast
$-5430691.99
2027 FCF Forecast
$-5412046.61
2028 FCF Forecast
$-5501345.38
2029 FCF Forecast
$-5474572.17
2030 FCF Forecast
$-5460155.79

Anixa Biosciences Net Income Forecast for 2023 - 2025 - 2030

In the last three years, Anixa Biosciences's Net Income has grown, rising from $-11.65M to $-13.60M – a growth of 16.74%. 0 analysts predict Anixa Biosciences's Net Income will decrease by 3.71% in the next year, reaching $-13.09M. By 2030, professionals predict that Anixa Biosciences's Net Income will decrease by 7.20%, to $-12.62M.

2023 NI Forecast
$-13094986.67
2024 NI Forecast
$-12067030.21
2025 NI Forecast
$-12372728.31
2026 NI Forecast
$-12781440.77
2027 NI Forecast
$-12902864.46
2028 NI Forecast
$-12618571.34
2029 NI Forecast
$-12539074.34
2030 NI Forecast
$-12620160.36

Anixa Biosciences EBITDA Forecast for 2023 - 2025 - 2030

Anixa Biosciences's EBITDA has seen impressive growth In the last two years, rising from $-11.00M to $-13.10M – a growth of 19.09%. In the following year, the 0 analysts surveyed believe that Anixa Biosciences's EBITDA will decrease by 12.02%, reaching $-11.53M. According to professionals, by 2030, Anixa Biosciences's EBITDA will have decreased by 11.08%, falling down to $-11.65M.

2022 EBITDA Forecast
$-11525380.00
2023 EBITDA Forecast
$-11491956.40
2024 EBITDA Forecast
$-11201592.97
2025 EBITDA Forecast
$-11819174.13
2026 EBITDA Forecast
$-11726590.59
2027 EBITDA Forecast
$-11654276.62
2028 EBITDA Forecast
$-11505878.83
2029 EBITDA Forecast
$-11609431.74
2030 EBITDA Forecast
$-11648903.81

Anixa Biosciences EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Anixa Biosciences's EBIT has grown by 21.01%, rising from $-11.47M to $-13.88M. The next year, 0 experts forecast that Anixa Biosciences's EBIT will decrease by 5.22%, reaching $-13.16M. In 2030, professionals predict that Anixa Biosciences's EBIT will decrease by 7.82%, reaching $-12.79M.

2023 EBIT Forecast
$-13155926.67
2024 EBIT Forecast
$-12222294.40
2025 EBIT Forecast
$-12540481.47
2026 EBIT Forecast
$-12983578.48
2027 EBIT Forecast
$-13056719.31
2028 EBIT Forecast
$-12773388.50
2029 EBIT Forecast
$-12698877.06
2030 EBIT Forecast
$-12794118.64

Anixa Biosciences EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Anixa Biosciences's EPS has fallen from $-0.57 to $-0.45 – a 21.05% decrease. For next year, analysts predict EPS of $-0.49, which would mean an increase of 9.11%. Over the next eight years, experts predict that Anixa Biosciences's EPS will grow at a rate of 3.83%.

2023 EPS Forecast
$-0.49
2024 EPS Forecast
$-0.47
2025 EPS Forecast
$-0.47
2026 EPS Forecast
$-0.46
2027 EPS Forecast
$-0.47
2028 EPS Forecast
$-0.47
2029 EPS Forecast
$-0.47
2030 EPS Forecast
$-0.47